BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12764538)

  • 1. Immunologic factors in transplant arteriopathy: insight from animal models.
    Alexis JD; Pyo RT; Chereshnev I
    Mt Sinai J Med; 2003 May; 70(3):191-6. PubMed ID: 12764538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of MCP-1/CCR2 signaling does not inhibit intimal proliferation in a mouse aortic transplant model.
    Alexis JD; Pyo RT; Chereshnev I; Katz J; Rollins BJ; Charo IF; Taubman MB
    J Vasc Res; 2008; 45(6):538-46. PubMed ID: 18463419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary arteriopathy postcardiac transplant in a heterotopic piglet model: the role of matrix-cytokine interaction.
    Clausell N; Coles J; Rabinovitch M
    Transplant Proc; 1993 Feb; 25(1 Pt 2):859-60. PubMed ID: 8442248
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased interleukin-1 beta and fibronectin expression are early features of the development of the postcardiac transplant coronary arteriopathy in piglets.
    Clausell N; Molossi S; Rabinovitch M
    Am J Pathol; 1993 Jun; 142(6):1772-86. PubMed ID: 8506947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidonor humoral transfer induces transplant arteriosclerosis in aortic and cardiac graft models in rats.
    Alkhatib B; Freguin-Bouilland C; Litzler PY; Jacquot S; Lallemand F; Henry JP; Thuillez C; Plissonnier D
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):791-7. PubMed ID: 17320586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of graft coronary arteriosclerosis after heart transplantation.
    Soukiasian HJ; Czer LS; Wang HM; Luthringer D; Wang C; Kamlot A; Quartel A; Trento A
    Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular adhesion molecules in transplantation.
    Rodriguez-Iturbe B
    Transplant Proc; 1996 Dec; 28(6):3285-9. PubMed ID: 8962274
    [No Abstract]   [Full Text] [Related]  

  • 8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adhesion molecules in synovial inflammation.
    Agarwal SK; Brenner MB
    Curr Opin Rheumatol; 2006 May; 18(3):268-76. PubMed ID: 16582691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac allograft vasculopathy: pathology, prevention and treatment.
    Kass M; Haddad H
    Curr Opin Cardiol; 2006 Mar; 21(2):132-7. PubMed ID: 16470150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody and complement in transplant vasculopathy.
    Wehner J; Morrell CN; Reynolds T; Rodriguez ER; Baldwin WM
    Circ Res; 2007 Feb; 100(2):191-203. PubMed ID: 17272820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of monocyte and lymphocyte adhesion molecules is increased in isolated coronary artery ectasia.
    Yildirim N; Tekin IO; Dogan SM; Aydin M; Gursurer M; Cam F; Gungorduk A; Akoz A
    Coron Artery Dis; 2007 Feb; 18(1):49-53. PubMed ID: 17172930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiographic, pathologic, and clinical relationships in coronary artery disease in cardiac allografts.
    Haddad M; Pflugfelder PW; Guiraudon C; Novick RJ; McKenzie FN; Menkis A; Kostuk WJ
    J Heart Lung Transplant; 2005 Sep; 24(9):1218-25. PubMed ID: 16143236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term preservation using a new apparatus combined with suppression of pro-inflammatory cytokines improves donor heart function after transplantation in a canine model.
    Oshima K; Takeyoshi I; Mohara J; Tsutsumi H; Ishikawa S; Matsumoto K; Morishita Y
    J Heart Lung Transplant; 2005 May; 24(5):602-8. PubMed ID: 15896759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allograft arteriopathy: pathogenesis update.
    Mitchell RN
    Cardiovasc Pathol; 2004; 13(1):33-40. PubMed ID: 14761783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VLA-4 and lymphocyte trafficking in immune-inflammatory states: novel therapeutic approaches in allograft arteriopathy.
    Molossi S; Rabinovitch M
    Springer Semin Immunopathol; 1995; 16(4):443-65. PubMed ID: 7570295
    [No Abstract]   [Full Text] [Related]  

  • 17. Proliferation signal inhibitors and cardiac allograft vasculopathy.
    Raichlin E; Kushwaha SS
    Curr Opin Organ Transplant; 2008 Oct; 13(5):543-50. PubMed ID: 19060540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of crystalloid, blood and Celsior solutions on porcine coronary endothelial function after heart transplantation.
    Perrault LP; El-Hamamsy I; Dumont E; Malo O; Carrier M
    J Heart Lung Transplant; 2005 Jul; 24(7):912-20. PubMed ID: 15982622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.